Health TrialsbyHealthPanel

MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors

1

Review clinical trials related to MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Evaluation of XYA02 in Patients With Advanced Solid Tumors

This study will evaluate the safety, tolerability, and efficacy of XYA02 in participants with advanced solid tumors.

Participants needed: 190
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: XYone Therapeutics, IncUpdated: Sep 25, 2026Locations: 5
Eligibility criteria

Signed informed consent form(s) (ICFs) obtained at Screening. [+13]

Has been refractory (did not have a tumor response) to previous treatment with a... [+13]

Read more